GLOBAL ANTIFUNGAL AGENTS MARKET FORECAST 2018-2026

GLOBAL ANTIFUNGAL AGENTS MARKET FORECAST 2018-2026

  • July 2018 •
  • 145 pages •
  • Report ID: 4796848
KEY FINDINGS
The global antifungal agents market is chiefly being propelled by factors like poor hygiene habits, supportive policies and programs by government and the development of drug resistance. By the end of the forecast period of 2018-2026, the market is likely to register a CAGR of 3.72%.

MARKET INSIGHTS
The antifungal agents market is segmented on the basis of drug types, therapeutic indications, types, applications, and geography.The antifungal agents market on the basis of drug types is segmented into systemic azoles, topical azoles, systemic polyenes, topical polyenes, systemic echinocandins, systemic antimetabolites, other systemic, other topical and other drugs types.

On the basis of therapeutic indications, the market includes aspergillosis market, dermatophytosis, candidiasis and others. Market by type includes prescription and over the counter drugs.The antifungal agents market by application is segregated into topical antifungal drugs and oral drugs. The antifungal drugs market on the basis of geography is segmented into Asia-Pacific, Europe, Rest of the World and North America.

REGIONAL INSIGHTS
North America antifungal drugs market possessed a colossal market share of the global antifungal agents market in 2017.A large number of people suffering from fungal infection and advancement in antifungal biopharmaceuticals in the region is upsurging the growth of the antifungal market.

On the other hand, the Asia-Pacific region is projected to be the fastest-growing region for the global antifungal agents market. The Europe antifungal drugs market is also estimated to grow at a healthy CAGR during the forecast period.

COMPETITIVE INSIGHTS
The leading market players in the global antifungal agents market are Abbott Laboratories, Strategic Initiatives, Arbor Pharmaceuticals, Inc, Baxter, Astellas Pharma Inc, Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer Laboratories, Merck & Co, Novartis, Pfizer, Sanofi-Aventis, and Vertex Pharmaceuticals.
Country=World Industry=OTC ParentIndustry=LifeSciences Date=201807 Publisher=InkwoodResearch Price=3000